Fibrofast and Fibrosis-4 versus Fibroscan as Indicators of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Cross-Sectional Study | ||||
African Journal of Gastroenterology and Hepatology | ||||
Volume 5, Issue 1, January 2022, Page 58-75 PDF (632.82 K) | ||||
Document Type: Original Clinical | ||||
DOI: 10.21608/ajgh.2022.153872.1010 | ||||
![]() | ||||
Authors | ||||
Rehab Badawi ![]() ![]() | ||||
1Tropical Medicine and Infectious Diseases Department, Faculty of Medicine, Tanta University, Tanta, Egypt. | ||||
2Clinical Pathology Department, Faculty of Medicine, Tanta University Hospital, El-Geesh St., Tanta, Egypt | ||||
3Basic Medical Science Department, Faculty of Dentistry, Majmaah University, Majmaah, 11952, Saudi Arabia. Public Health and Community Department, Faculty of Medicine, Tanta University, El-Geesh St., Tanta, Egypt | ||||
Abstract | ||||
Aims: Non-alcoholic fatty liver disease (NAFLD) is a broad category for a disease spectrum that includes simple steatosis, which can proceed to non-alcoholic steatohepatitis, cirrhosis, and, finally, hepatocellular carcinoma. Due to the invasive nature of liver biopsy, non-invasive diagnostic tools were required. Objective: To compare the performance of simple biochemical scores (fibroblast) FIB-5 and (fibrosis-4) FIB-4 with fibroscan to differentiate mild to moderate fibrosis (MF; F0 to F2) from advanced fibrosis (AF; F3 to F4) in patients with NAFLD. Patients and methods: This cross-sectional study was done on 116 NAFLD patients. All patients were scanned with the FibroScan examination. FIB-5 and FIB-4 were calculated for all patients. Results: The mean kPa score (liver stiffness measurement score) of the patients belonging to advanced fibrosis [9.53 ± 1.05]. The FIB-4 score was significantly higher in patients with advanced fibrosis (1.54 ± 0.38) compared with patients with mild to moderate fibrosis (1.18 ± 0.44), p-value = 0.001, whereas the FIB-5 score was insignificant between patients. Conclusion: FIB-4 is superior to FIB-5 as a simple, non-invasive marker for diagnosing advanced fibrosis in NAFLD patients. | ||||
Keywords | ||||
fibroscan; liver biopsy; non-invasive markers; FIB-5; FIB-4; non-alcoholic fatty liver disease; CAP; liver fibrosis; LSM; fatty liver | ||||
Supplementary Files
|
||||
Full Text | ||||
References | ||||
Statistics Article View: 733 PDF Download: 644 |
||||